Skip to content
Use caution Medical device recall · FDA · Published March 23, 2024

Philips 5000 Compact Ultrasound Systems Recall: Risk of Patient Burns

Philips recalls 5000 Compact Series ultrasound systems with Deluxe/Premium Carts that may cause patient burns due to temperature issues when transducers are misconfigured.

🇺🇸 FDA recall #Z-1757-2024Medical devicePhilips ›
Take action

Contact the company

Recalling firmPhilips Ultrasound, Inc.22100 Bothell Everett Hwy · Bothell, WA 98021-8431
✎ GovInfoNow plain-language explainer

Philips is recalling 5000 Compact Series ultrasound systems purchased with Deluxe or Premium Carts (model numbers 5500 CV/795141, 5500 P/795143, etc.) because they can cause patient burns if the transducer settings are not properly selected. This is a safety risk for medical staff using the equipment. Read more at govinfonow.com/recall/55716-philips-5000-compact-ultrasound-systems-recall-risk-of-patient-burns.

Source Summary by GovInfoNow · govinfonow.com/recall/55716-philips-5000-compact-ultrasound-systems-recall-risk-of-patient-burns · Updated August 19, 2026 · FDA enforcement record: FDA #Z-1757-2024

Cite this page

“Philips 5000 Compact Ultrasound Systems Recall: Risk of Patient Burns.” GovInfoNow, updated August 19, 2026. https://govinfonow.com/recall/55716-philips-5000-compact-ultrasound-systems-recall-risk-of-patient-burns. Based on FDA recall #Z-1757-2024 (https://api.fda.gov/device/enforcement.json?search=recall_number:%22Z-1757-2024%22&limit=1).

The FDA announced on March 23, 2024, that Philips Ultrasound, Inc. is recalling 5000 Compact Series Ultrasound Systems due to a risk of patient burns. The hazard involves the transesophageal echocardiography transducer potentially exceeding temperature limits without proper monitoring or control.

How to tell if you have it

  • Brand: Philips
  • Product: 5000 Compact Series Ultrasound Systems
  • Product/REF: 5500 CV/795141, 5500 P/795143, 5500 W/795144, 5500 G/795145, 5300 W/795146, 5300 P/795147, 5300 G/795148
  • Manufactured on or before 20-Dec-2023
  • Purchased with Deluxe and Premium Cart options
  • Units affected: 363

The hazard

The ultrasound system may have power but no temperature monitoring or control for the transesophageal echocardiography transducer, which can result in temperatures above the limit and cause patient burns. This occurs when the TEE is connected but not selected, when non-TEE imaging continues, or when a selected imaging transducer is removed.

Context

GovInfoNow's records show Philips Ultrasound, Inc. has issued 14 other recalls since April 29, 2019. Recent brand recalls include the Philips L17-5 Ultrasound Transducer Recall on Sept. 5, 2025, and the Philips S7-2t Transducer Probe Recall on July 3, 2025, both addressing useful life labeling clarifications. Other recent recalls of similar products include the Philips Brilliance CT 64 Medical Scanner Recall (Aug. 7, 2026) for unintended radiation risk and the Lutronic DermaV Laser System Recall (Aug. 6, 2026) for patient burn risks.

How to tell if you have this one

Check if your Philips ultrasound system has model numbers 5500 CV/795141, 5500 P/795143, 5500 W/795144, 5500 G/795145, or 5300 W/795146, 5300 P/795147, 5300 G/795148. These systems were manufactured on or before December 20, 2023, and purchased with Deluxe or Premium Carts.

  • Brand
    Philips
  • Category
    Medical device
Based on the official FDA remedy

What to do — step by step

  1. Check System Settings

    Ensure the transducer is properly selected before imaging to prevent overheating and potential burns.

  2. Verify Cart Type

    Confirm your system was purchased with a Deluxe or Premium Cart that includes multiport adapters.

Where it went and when

Where it was distributed

Distributed nationwide and abroad; the notice names 25 states.

Alaska: nationwideAKMaine: named in the noticeMEVermont: nationwideVTNew Hampshire: named in the noticeNHWashington: nationwideWAIdaho: nationwideIDMontana: nationwideMTNorth Dakota: nationwideNDMinnesota: nationwideMNIllinois: named in the noticeILWisconsin: nationwideWIMichigan: named in the noticeMINew York: named in the noticeNYRhode Island: nationwideRIMassachusetts: named in the noticeMAOregon: nationwideORNevada: nationwideNVWyoming: nationwideWYSouth Dakota: nationwideSDIowa: nationwideIAIndiana: named in the noticeINOhio: named in the noticeOHPennsylvania: named in the noticePANew Jersey: nationwideNJConnecticut: named in the noticeCTCalifornia: named in the noticeCAUtah: named in the noticeUTColorado: named in the noticeCONebraska: nationwideNEMissouri: nationwideMOKentucky: named in the noticeKYWest Virginia: nationwideWVVirginia: named in the noticeVAMaryland: named in the noticeMDDelaware: nationwideDEArizona: nationwideAZNew Mexico: named in the noticeNMKansas: named in the noticeKSArkansas: nationwideARTennessee: named in the noticeTNNorth Carolina: named in the noticeNCSouth Carolina: named in the noticeSCDistrict of Columbia: nationwideDCOklahoma: named in the noticeOKLouisiana: nationwideLAMississippi: nationwideMSAlabama: nationwideALGeorgia: named in the noticeGAHawaii: nationwideHITexas: named in the noticeTXFlorida: named in the noticeFLPuerto Rico: named in the noticePR

FDA distribution: “Worldwide - US Nationwide distribution including in the states of CA, CO, CT, FL, GA, IL, IN, KS, KY, MA, MD, ME, MI, NC, NH, NM, NY, OH, OK, PA, PR, SC, TN, TX, UT, VA and the countries of Australia, Austria, Bahrain, Brazil, Bulgaria,…” States read from FDA’s own wording; “not listed” means the notice does not name it.

Named in the notice: California, Colorado, Connecticut, Florida, Georgia, Illinois, Indiana, Kansas, Kentucky, Maine, Maryland, Massachusetts, Michigan, New Hampshire, New Mexico, New York, North Carolina, Ohio, Oklahoma, Pennsylvania, Puerto Rico, South Carolina, Tennessee, Texas, Utah, Virginia.

Recall timeline

FDA published this recall 53 days after the firm started it.

1. Firm started the recall: Mar 23, 202412. FDA classified it Class II: May 3, 202423. Published in FDA’s Enforcement Report: May 15, 202432024
  1. Firm started the recall
  2. FDA classified it Class II
  3. Published in FDA’s Enforcement Report

Dates from the agency record only; steps without a date are left out.

Similar recalls

Latest medical device recalls

Keep exploring

Where this comes from

The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.

  • Official source: FDA Recall #Z-1757-2024 (March 23, 2024) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for Z-1757-2024 to see it in context.
  • Plain-language summary written by qwen3:4b on August 19, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
  • GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.
GovInfoNow is an independent guide. We are not FDA or any government agency. Always confirm details with the official recall.Data: CPSC · FDA · NHTSA · USDA